Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (AU:NXS)
ASX:NXS
Next Science Ltd (NXS) Share Price & Analysis
4 Followers
NXS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.18 - AU$0.67
Previous CloseAU$0.38
Volume25.93K
Average Volume (3M)120.76K
Market Cap
AU$109.39M
Enterprise ValueAU$103.52M
Total Cash (Recent Filing)$5.11M
Total Debt (Recent Filing)$1.22M
Price to Earnings (P/E)-3.6
Beta0.52
Next Earnings
Aug 28, 2024EPS Estimate
-AU$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding291,695,103
10 Day Avg. Volume187,546
30 Day Avg. Volume120,757
Standard Deviation0.36
R-Squared0.13
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.31
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.37Price Target Upside11.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Next Science Ltd News
PremiumCompany Announcements
Next Science Ltd Announces Director’s Departure
PremiumCompany Announcements
Next Science Shareholders Show Solid Support at AGMPremiumCompany Announcements
Next Science Ltd Reports Record Growth
PremiumCompany Announcements
Next Science Targets $12.5bn Healthcare OpportunityPremiumCompany Announcements
Next Science Optimizes Sales Strategy for Growth
PremiumCompany Announcements
Next Science’s Surgical Solution Shows Promise
PremiumCompany Announcements
Next Science’s Breakthrough in Infection PreventionPremiumCompany Announcements
Next Science’s XPERIENCE™ Proves Effective in SurgeryOptions Prices
Currently, No data available
---
Ownership Overview
3.33% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
96.67% Public Companies and
Individual Investors
NXS FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest share price was AU$0.18 and its highest was AU$0.67 in the past 12 months.
What is Next Science Ltd’s market cap?
Currently, no data Available
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 104 days.
How were Next Science Ltd’s earnings last quarter?
Currently, no data Available
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Undervalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate is -AU$0.02.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 291,695,100 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in AU:NXS
---
Next Science Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.37 (11.61% Upside)
AU$0.37 (11.61% Upside)
Blogger Sentiment
Bullish
AU:NXS Sentiment 92%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.88%
12-Months-Change
Fundamentals
Return on Equity
-156.02%
Trailing 12-Months
Asset Growth
43.67%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Ltd is an Australia based company formed to commercialise and develop its Xbio technology, which is a non-toxic technology with efficacy in eradicating both biofilm based and free-floating bacteria. The company's products includes SurgX Sterile wound Gel, Bactisure Surgical Lavage and Blast X Wound Gel.
---
NXS Stock 12 Month Forecast
Average Price Target
AU$0.37
▲(11.61% Upside)
Technical Analysis
Next Science Ltd
―
vTv Therapeutics
―
Novavax
―
Inovio Pharmaceuticals
―
Traws Pharma
―
Best Analysts Covering NXS
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
-27.13%
reiterated a buy rating 23 days ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -27.13% per trade.
---